Pacira BioSciences Inc (PCRX) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

PCRX rapporto: 63%

100%

PCRX supera 22 di 35 ultime stime

Data del prossimo reportMar 6, 2025

Stimato per Q4 24:$0.61

Cambiamenti implicati per il Q3 24:+15.09%

Cambiamenti implicati per il Q4 23:-14.08%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q3 24	Nov 6, 2024	$0.53 / $0.5	$0.03 / 6%
Q2 24	Jul 30, 2024	$0.64 / $0.53	$0.11 / 20.75%
Q1 24	May 7, 2024	$0.42 / $0.46	$-0.04 / -8.7%
Q4 23	Feb 29, 2024	$0.71 / $0.71	$0 / -
Q3 23	Nov 2, 2023	$0.52 / $0.65	$-0.13 / -20%
Q2 23	Aug 2, 2023	$0.61 / $0.59	$0.02 / 3.39%
Q1 23	May 3, 2023	$0.32 / $0.4	$-0.08 / -20%
Q4 22	Feb 28, 2023	$0.6 / $0.71	$-0.11 / -15.49%

Fornitori di Dati: Xignite Logo